Session

IBD (Posters)

EVALUATION OF THE ROLE OF ENTERIC NEURONS AND INTERSTITIAL CELLS IN COLONIC INFLAMMATION IN THE MOUSE MODEL OF DSS-INDUCED COLITIS
EVALUATION OF THE ROLE OF ENTERIC NEURONS AND INTERSTITIAL CELLS IN COLONIC INFLAMMATION IN THE MOUSE MODEL OF DSS-INDUCED COLITIS

IBD (Posters)  et al.

SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501

IBD (Posters)  et al.

ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

ENDOSCOPIC AND HISTOLOGIC ACTIVITY ASSESSMENT CONSIDERING DISEASE EXTENT AND PREDICTION OF TREATMENT FAILURE IN ULCERATIVE COLITIS
ENDOSCOPIC AND HISTOLOGIC ACTIVITY ASSESSMENT CONSIDERING DISEASE EXTENT AND PREDICTION OF TREATMENT FAILURE IN ULCERATIVE COLITIS

IBD (Posters)  et al.

OVERABUNDANCE OF SERUM IMMUNOGLOBULIN G SPECIFIC TO ESCHERICHIA COLI STRAINS AS ONE OF THE FEATURES OF CROHN´S DISEASE
OVERABUNDANCE OF SERUM IMMUNOGLOBULIN G SPECIFIC TO ESCHERICHIA COLI STRAINS AS ONE OF THE FEATURES OF CROHN´S DISEASE

IBD (Posters)  et al.

TRANSCRIPTOMIC INSIGHT INTO IN VITRO INTERACTION OF ESCHERICHIA COLI WITH IMMUNOGLOBULIN A AS A MODEL OF THE INFLAMMATORY BOWEL DISEASE PATHOGENESIS
TRANSCRIPTOMIC INSIGHT INTO IN VITRO INTERACTION OF ESCHERICHIA COLI WITH IMMUNOGLOBULIN A AS A MODEL OF THE INFLAMMATORY BOWEL DISEASE PATHOGENESIS

IBD (Posters)  et al.

TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS
TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS

IBD (Posters)  et al.

WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY
WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY

IBD (Posters)  et al.

KNOCKDOWN OF MUC1 AND MUC13 IN INFLAMED INTESTINAL EPITHELIAL CELLS AFFECTS EXPRESSION OF KEY GENES INVOLVED IN INTESTINAL BARRIER HOMEOSTASIS
KNOCKDOWN OF MUC1 AND MUC13 IN INFLAMED INTESTINAL EPITHELIAL CELLS AFFECTS EXPRESSION OF KEY GENES INVOLVED IN INTESTINAL BARRIER HOMEOSTASIS

IBD (Posters)  et al.

IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY
IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY

IBD (Posters)  et al.

POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF
POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF

IBD (Posters)  et al.

NO ASSOCIATION BETWEEN POST-INFLAMMATORY PSEUDOPOLYPS AND COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
NO ASSOCIATION BETWEEN POST-INFLAMMATORY PSEUDOPOLYPS AND COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

EFFICACY, SAFETY AND DRUG SURVIVAL OF THIOGUANINE AS MAINTENANCE TREATMENT FOR INFLAMMATORY BOWEL DISEASE: A MULTI-CENTRE UK STUDY
EFFICACY, SAFETY AND DRUG SURVIVAL OF THIOGUANINE AS MAINTENANCE TREATMENT FOR INFLAMMATORY BOWEL DISEASE: A MULTI-CENTRE UK STUDY

IBD (Posters)  et al.

ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

COMBINED MEDICAL AND SURGICAL THERAPY IN COMPLEX PERIANAL CROHN´S DISEASE - EFFICACY AND PREDICTIVE FACTORS FOR THERAPEUTIC FAILURE
COMBINED MEDICAL AND SURGICAL THERAPY IN COMPLEX PERIANAL CROHN´S DISEASE - EFFICACY AND PREDICTIVE FACTORS FOR THERAPEUTIC FAILURE

IBD (Posters)  et al.

NAD IMMUNOMETABOLISM IN NK CELL BIOLOGY DURING INTESTINAL INFLAMMATION
NAD IMMUNOMETABOLISM IN NK CELL BIOLOGY DURING INTESTINAL INFLAMMATION

IBD (Posters)  et al.

PERCEPTION OF THE ROLE OF FOOD AND DIETARY MODIFICATIONS IN THE GENESIS OF SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IMPACT ON LIFE STYLE
PERCEPTION OF THE ROLE OF FOOD AND DIETARY MODIFICATIONS IN THE GENESIS OF SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IMPACT ON LIFE STYLE

IBD (Posters)  et al.

BODY COMPOSITION ANALYSIS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
BODY COMPOSITION ANALYSIS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

VENOUS THROMBOEMBOLISM AFTER RECENT INFLAMMATORY BOWEL DISEASE FLARE: OUTCOMES AND PREDICTORS
VENOUS THROMBOEMBOLISM AFTER RECENT INFLAMMATORY BOWEL DISEASE FLARE: OUTCOMES AND PREDICTORS

IBD (Posters)  et al.

AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?
AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?

IBD (Posters)  et al.

Item 521 - 540 / 558
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
27
28